COMMUNIQUÉS West-GlobeNewswire

Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure
25/09/2019
Data indicate ITI-214 at a dose of 30 mg is well tolerated with a favorable safety profile Study ‘104 now proceeding to a third cohort at a dose of 90 mg NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular [...]
RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019
25/09/2019
RTI announces interim clinical outcomes on 150 patients at 6-month follow-up in the EVoluSIon study for the SImmetry® Sacroiliac Joint Fusion System showing statistically significant reductions in pain of 56% and opioid [...]
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer
25/09/2019
Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) TORONTO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative [...]
Microbix Presenting at Muskoka Capital Conference
25/09/2019
Meetings with Growth-Oriented Investors, September 27-29, 2019 MISSISSAUGA, Ontario, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and [...]
Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria
25/09/2019
– Danicopan Phase 2 PNH combination therapy topline data expected Q4 2019 – – Initiation of Phase 3 planned for early 2020 – BLUE BELL, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: [...]
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
25/09/2019
-- Four new MC4R pathway obesity indications added to Phase 2 Basket Study and enrolling patients -- -- Genetic sequencing of 13,567 individuals with severe obesity yields 11.7 percent (1,584 individuals) who have a [...]
Orchard Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa
25/09/2019
BOSTON and LONDON, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
Summit Therapeutics to Host R&D Day 7 October 2019
25/09/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Host R&D Day 7 October 2019 Oxford, UK, and Cambridge, MA, US, 25 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today [...]
Matinas BioPharma Announces Pre-Screening of Patients to Determine Eligibility for Phase 2 ENHANCE-IT Study Against Vascepa®
25/09/2019
BEDMINSTER, N.J., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that it has commenced pre-screening patients to [...]
Teleflex Announces Tenth Anniversary of GuideLiner® Catheter Product Line
25/09/2019
Company Celebrates 10 Years of the Industry's Leading Guide Extension Catheter with More Than 1 Million Units Sold Worldwide WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading [...]
Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion
25/09/2019
Press release Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB ("Acarix" or the "Company") has [...]
Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting
25/09/2019
– Late-Breaking Abstract of the positive SANET-ep Phase III trial of surufatinib in patients with non-pancreatic neuroendocrine tumors (“NET”) to be presented – – Conference call and webcast with lead trial [...]
Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
25/09/2019
Continued strong progress since IPO in February 2019: Commenced POSEIDON pivotal study to support approval of the alfa pump® in the U.S. & Canada Achieved clinical proof-of-concept of Direct Sodium Removal (DSR), [...]
Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)
25/09/2019
Study aims to support the approval of the alfa pump in U.S. and Canada Results anticipated by mid-2021 U.S. launch of the alfa pump planned for H1 2022 GHENT, Belgium, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Sequana Medical [...]
ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2019 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON SEPTEMBER 30, 2019
25/09/2019
Geneva, Switzerland, September 25, 2019 – Addex Therapeutics (SIX:ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, will discuss its half-year 2019 financial results, [...]
Align Technology Further Advances Digital Dentistry in China With the Launch of the iTero Element 2 Scanner
25/09/2019
Receives approval from China ’s National Medical Products Administration to manufacture and sell the iTero Element 2 Scanner in China Provides localized technology and manufacturing capabilities to better serve China [...]
‘Better together’: Mental Health Commission of Canada and Canadian Mental Health Association announce strengthened collaboration
25/09/2019
From Mental Health Commission of Canada TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- At the Canadian Mental Health Association’s (CMHA) national Mental Health For All conference in Toronto today, CMHA and the Mental [...]
« Mieux ensemble » : Renforcement de la collaboration entre la Commission de la santé mentale du Canada et l’Association canadienne pour la santé mentale
25/09/2019
De la Commission de la santé mentale du Canada TORONTO, 24 sept. 2019 (GLOBE NEWSWIRE) -- Lors de son Congrès annuel La santé mentale pour tous aujourd’hui à Toronto, l’Association canadienne pour la santé mentale (ACSM [...]
Bone Bank Allografts Launches Global Sales Force Initiative
24/09/2019
Distributor Expansion to Support Growing Demand for Orthobiologics SAN ANTONIO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical [...]

Pages